|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2021―Nov―09 |
Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review |
Kavous Shahsavarinia, Morteza Ghojazadeh, Sarvin Sanaie, Leila Vahedi, Mahta Ahmadpour, Ata Mahmoodpoor, Hassan Soleimanpour |
2 |
[GO] |
2021―Sep―30 |
Natural products as inhibitors of COVID-19 main protease-A virtual screening by molecular docking |
Marzieh Omrani, Mohammad Bayati, Parvaneh Mehrbod, Kamal Asmari Bardazard, Samad Nejad-Ebrahimi |
3 |
[GO] |
2021―Sep―30 |
Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease |
Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Mohammed Dahab, Ahmed Metwaly, Ibrahim Eissa |
4 |
[GO] |
2021―Sep―30 |
Potential Sedative and Therapeutic Value of Dexmedetomidine in Critical COVID-19 patients |
Saeid Safari, Alireza Jahangirifard, Alireza Zali, Alireza Salimi, Ehsan Bastanhagh, Reza Aminnejad, Reza Jalili Khoshnood, Davood Ommi |
5 |
[GO] |
2021―Sep―30 |
The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: A systematic review and meta-analysis |
Leila Nikniaz, Mohammad Amin Akbarzadeh, Hossein Hosseinifard, Mohammad-Salar Hosseini |
6 |
[GO] |
2021―Sep―30 |
Acyclovir as a Potential Adjuvant Therapy in COVID-19 Treatment Regimens |
Fatemeh Heidary, Sedigheh Madani, Reza Gharebaghi, Fahimeh Asadi-amoli |
7 |
[GO] |
2021―Sep―30 |
Potential Roles of Vitamins in the Management of COVID-19: A Comprehensive Review |
Homa Rezaei, Sajad Khiali, Haleh Rezaee, Hossein Bannazadeh Baghi, Matin Pourghasem, Taher Entezari-Maleki |
8 |
[GO] |
2021―Sep―30 |
The clinical characteristics and treatment approaches of COVID-19: a concise review |
Sajjad Eslamkhah, Nazila Alizadeh, Khalil Hajiasgharzadeh, Masoud Eslamkhah, Ahad Mokhtarzadeh, Behzad Baradaran |
9 |
[GO] |
2021―Sep―30 |
A new possible indication of direct-acting anti-hepatitis C drugs in the therapeutic management of COVID-19: A narrative literature review |
Alireza Mashhadi Hemmatabadi, Fatemeh Jafari, Hesamoddin Hosseinjani |
10 |
[GO] |
2021―Sep―30 |
Anti-rheumatic drugs as potential anti-inflammatory, immunomodulatory agents against COVID-19: A systematic review |
Reza Sinaei, Sara Pezeshki, Ali Asadipour, Reza Shiari, Roya Sinaei, Ali Sinaei |
11 |
[GO] |
2021―Sep―30 |
The Integration of Pharmacophore-Based 3D QSAR Modeling and Virtual Screening in Identification of Natural Product Inhibitors against SARS-CoV-2 |
Samira Norouzi, Maryam Farahani, Samad Nejad Ebrahimi |
12 |
[GO] |
2021―Sep―30 |
Qualitative and quantitative analysis of anti-viral compounds against SARS-CoV-2 protease enzyme by molecular dynamics simulation and MM/PBSA method |
Saghi Sepehri, Niloufar Hashemidanesh, Karim Mahnam, Hila Asham |
13 |
[GO] |
2020―Dec―20 |
Dexmedetomidine: An All Sedation-in-One Drug in Critically Ill Patients with COVID-19 |
Ata Mahmoodpoor, Elyad Ekrami, Hassan Soleimanpour |
14 |
[GO] |
2020―Dec―20 |
Plasmapheresis: A New Strategy in the Treatment of COVID-19 |
Punet Kumar, Md Iftekhar Ahmad, Sangam Singh |
15 |
[GO] |
2020―Dec―20 |
A Rapid Strategy for Repurposing Drugs for COVID-19 |
Maryam Khoubnasabjafari, Masoud Amanlou, Ahmadreza Dehpour, Abolghasem Jouyban |
16 |
[GO] |
2020―Dec―20 |
Higher Education System in Light of Covid-19 |
Jalal Hanaee, Mohammad Reza Rashidi |
17 |
[GO] |
2020―Dec―20 |
Diabetes and the COVID-19 Pandemic: What Should the Diabetes Patients Know? |
Moyad Shahwan, Nageeb Hassan, Sahab Alkhoujah, Ammar Jairoun, Samer Zyoud, Sudhir Varma |
18 |
[GO] |
2020―Dec―20 |
COVID-19: A Devastating Pandemic |
Punet Kumar, Md Iftekhar Ahmad, Sangam Singh |
19 |
[GO] |
2020―Dec―20 |
NSAIDs and COVID-19: A New Challenging Area |
Hananeh Baradaran, Hadi Hamishehkar, Haleh Rezae |
20 |
[GO] |
2020―Dec―20 |
COVID-19: Clinical Characteristics and Molecular Levels of Candidate Compounds of Prospective Herbal and Modern Drugs in Indonesia |
Robert Tungadi, Teti Sutriyati Tuloli, Widysusanti Abdulkadir, Nurain Thomas, Madania Madania, Ani Mustapa Hasan, Zulfiayu Sapiun |
21 |
[GO] |
2020―Dec―20 |
A Summary of Coronavirus Disease 2019: What We Should Know? |
Ysrafil Ysrafil, Indwiani Astuti, Rosdiana Mus, Noviyanty Indjar Gama, Dwi Rahmaisyah, Riskah Nur’amalia |
22 |
[GO] |
2020―Dec―20 |
Prophylactic Use of Chloroquine May Impair Innate Immune System Response against SARS-Cov-2 |
Hamid Soraya |
23 |
[GO] |
2020―Dec―20 |
In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2 |
Baby Krishnaprasad, Swastika Maity, Chetan Mehta, Akhil Suresh, Usha Y Nayak, Yogendra Nayak |
24 |
[GO] |
2020―Dec―20 |
Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors |
Mohammad Rizki Fadhil Pratama, Hadi Poerwono, Siswandono Siswodihardjo |
25 |
[GO] |
2020―Dec―20 |
Persistence of SARS-Cov-2 on the Beauty Products, Their Containers’ Surfaces, and the Possibility of Secondary and Cross-Contamination |
Zahra Jannatdoust, Sara Shamekhi, Jalal Hanaee, Somaieh Soltani, Alireza Garjani |
26 |
[GO] |
2020―Dec―20 |
Investigational Drugs for the COVID 19 Pandemic - A Concise Review |
Reena Sherin Parveen, Sherya Hegde, Veena Nayak |